HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CAF protocol

chemotherapy protocol consisting of above cpds
Also Known As:
FAC protocol; Neo-FAC; PEGASE 02 regimen
Networked: 6 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Demirci, Umut: 1 article (11/2011)
2. Alsancak, Yakup: 1 article (11/2011)
3. Yalcin, Ridvan: 1 article (11/2011)
4. Tanindi, Asli: 1 article (11/2011)
5. Benekli, Mustafa: 1 article (11/2011)
6. Tacoy, Gulten: 1 article (11/2011)
7. Coskun, Ugur: 1 article (11/2011)
8. Buyukberber, Suleyman: 1 article (11/2011)
9. Li, Q: 1 article (03/2001)
10. Qu, F: 1 article (03/2001)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
10/01/1999 - "Patients with poor-prognosis stage IV breast cancer were treated with this "neo-FAC" as front-line therapy. "
03/01/2001 - "A total of 121 patients with small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC) and breast cancer (BC) were randomized into carboplatin injection group (study group) and carboplatin powder group (control group), treated with CE, CIE and CAF protocol, respectively. "
10/01/1999 - "'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast cancer: a Southwest Oncology Group Phase II Study."
11/01/2011 - "Thirty-seven consecutive patients with newly diagnosed breast cancer who were planned to receive either AC protocol [cyclophosphamide (600 mg/m(2)) + adriamycin (60 mg/m(2))] or CAF protocol [cyclophosphamide (600 mg/m(2)) + adriamycin (60 mg/m(2)) + 5-fluorouracil (600 mg/m(2))] for six cures were enrolled between February 2009 and June 2010. "
10/01/1998 - "Considering the recommended dose of the docetaxel/doxorubicin combination (75 mg/m2 and 50 mg/m2, respectively), we decided to proceed with a pilot program in untreated metastatic breast cancer aimed at defining a multidrug regimen that could be later randomly compared with a standard doxorubicin-containing polychemotherapy regimen with equidoses of doxorubicin such as the FAC protocol (5-fluorouracil 500 mg/m2, doxorubicin 50 mg/m2, and cyclophosphamide 500 mg/m2) in first-line metastatic and adjuvant treatment of breast cancer patients. "
2. Small Cell Lung Carcinoma (Small Cell Lung Cancer)
3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
4. Anticipatory Vomiting
5. Vomiting

Related Drugs and Biologics

1. Fluorouracil (Carac)
2. Doxorubicin (Adriamycin)
3. Cyclophosphamide (Cytoxan)
4. Carboplatin (JM8)
5. Vincristine (Oncovin)
6. Methotrexate (Mexate)
7. docetaxel (Taxotere)
8. CMF protocol
9. AC protocol (CA protocol)

Related Therapies and Procedures

1. Radical Mastectomy
2. Combination Drug Therapy (Combination Chemotherapy)
3. Drug Therapy (Chemotherapy)